Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03663166
Recruitment Status : Active, not recruiting
First Posted : September 10, 2018
Last Update Posted : November 17, 2021
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : October 21, 2021
Estimated Study Completion Date : March 1, 2027